Boston Angel Investors →
CEO and Co-Founder, Tamr
Serial Entrepreneur and Investor
Founding Director, Massachusetts Technology Transfer Center
Head of global research and development at Life Technologies
Managing director, the Foundry Group
VP of Research and Special Initiatives, Google
CEO and co-founder of BoostSuite
Chairman, CEO, & Founder, Alexandria Real Estate Equities
May 11, 2017 ·
May 31, 2017 ·
June 8, 2017 ·
NKT Therapeutics is developing drugs that target a class of immune cells known as natural killer T cells.
Xconomy offers a number of ways to subscribe for free!
Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit/Ann Arbor, San Francisco, New York, Raleigh-Durham, Boulder/Denver, Texas, Wisconsin, Indiana, and beyond.
© 2007-2017, Xconomy, Inc.
Xconomy is a registered service mark of Xconomy, Inc.
All rights reserved.
Website development support from Andrew Koyfman with design support from Rob Hunter.